Insider · CIK 0001196201
Kathleen Laporte
director
Files at PRPO (Precipio, Inc.), BOLT (Bolt Biotherapeutics, Inc.), QTTB (Q32 Bio Inc.), ETNB (89bio, Inc.), CERO (CERO THERAPEUTICS HOLDINGS, INC.). First filing Sep 10, 2025, latest Sep 10, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $123k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PRPO: Precipio, Inc.
PRPOOct 9, 2026 · close 23.12
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | PRPOsell Precipio, Inc. | $123k 6,152 shares | -50% | +366% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +1,392 | - | - | 1,392 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | DDisposition to issuer Director Stock Option (Right to Buy)derivative | -1,392 | - | - | 0 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +1,250 | - | - | 1,250 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | DDisposition to issuer Director Stock Option (Right to Buy)derivative | -1,250 | - | - | 0 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +1,250 | - | - | 1,250 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | DDisposition to issuer Director Stock Option (Right to Buy)derivative | -1,250 | - | - | 0 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +1,250 | - | - | 1,250 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | DDisposition to issuer Director Stock Option (Right to Buy)derivative | -1,250 | - | - | 0 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +1,250 | - | - | 1,250 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | DDisposition to issuer Director Stock Option (Right to Buy)derivative | -1,250 | - | - | 0 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +1,100 | - | - | 1,100 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | DDisposition to issuer Director Stock Option (Right to Buy)derivative | -1,100 | - | - | 0 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +1,100 | - | - | 1,100 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | DDisposition to issuer Director Stock Option (Right to Buy)derivative | -1,100 | - | - | 0 | Dec 16, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -25,000 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,500 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -27,400 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -45,150 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -56,400 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 23, 2025 | QTTB Q32 Bio Inc. | AGrant or award Stock Option (Right to Buy)derivative | +53,521 | $0.00 | $0 | 53,521 | Oct 27, 2025 |
| Oct 15, 2025 | PRPO Precipio, Inc. | AGrant or award Common Stock | +711 | $17.58 | $12k | 6,862 | Oct 16, 2025 |
| Sep 8, 2025 | PRPO Precipio, Inc. | SOpen-market sale Common Stock | -6,152 | $20.06 | $123k | 6,151 | Sep 10, 2025 |
| May 27, 2025 | BOLT Bolt Biotherapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +1,100 | $0.00 | $0 | 1,100 | Jul 2, 2025 |
| May 30, 2025 | CERO CERO THERAPEUTICS HOLDINGS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +9,326 | $0.00 | $0 | 9,326 | Jun 2, 2025 |
| Apr 15, 2025 | PRPO Precipio, Inc. | AGrant or award Common Stock | +2,232 | $5.60 | $12k | 12,303 | Apr 17, 2025 |
| Mar 4, 2025 | CERO CERO THERAPEUTICS HOLDINGS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +17,923 | $0.00 | $0 | 17,923 | Mar 6, 2025 |
| Feb 24, 2025 | QTTB Q32 Bio Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -5,431 | $0.00 | $0 | 0 | Feb 27, 2025 |
| Feb 24, 2025 | QTTB Q32 Bio Inc. | AGrant or award Stock Option (Right to Buy)derivative | +5,431 | $0.00 | $0 | 5,431 | Feb 27, 2025 |
| Feb 24, 2025 | QTTB Q32 Bio Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,947 | $0.00 | $0 | 0 | Feb 27, 2025 |
| Feb 24, 2025 | QTTB Q32 Bio Inc. | AGrant or award Stock Option (Right to Buy)derivative | +1,947 | $0.00 | $0 | 1,947 | Feb 27, 2025 |
| Feb 24, 2025 | QTTB Q32 Bio Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,767 | $0.00 | $0 | 0 | Feb 27, 2025 |
| Feb 24, 2025 | QTTB Q32 Bio Inc. | AGrant or award Stock Option (Right to Buy)derivative | +12,767 | $0.00 | $0 | 12,767 | Feb 27, 2025 |
| Feb 24, 2025 | CERO CERO THERAPEUTICS HOLDINGS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +127,500 | $0.00 | $0 | 255,000 | Feb 26, 2025 |
| Feb 3, 2025 | ETNB 89bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +56,400 | $0.00 | $0 | 56,400 | Feb 5, 2025 |
| Jan 14, 2025 | PRPO Precipio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +1,000 | $0.00 | $0 | 1,000 | Jan 16, 2025 |
| Dec 2, 2024 | CERO CERO THERAPEUTICS HOLDINGS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +127,500 | $0.00 | $0 | 127,500 | Dec 4, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.